Business Standard

RPG Life Sciences zooms 20% as PBT jumps four-fold in Q2

Meanwhile, operational revenue during the quarter grew 8.8 per cent at Rs 98.49 crore, as against Rs 90.5 crore in the corresponding quarter of the previous year.

Pharma
Premium

SI Reporter Mumbai
Shares of RPG Life Sciences were locked in the upper circuit band of 20 per cent at Rs 255 on the BSE on Thursday after the company’s profit before tax (PBT) jumped four-fold to Rs 12.04 crore in the September quarter of FY20 (Q2FY20). The company, engaged in manufacturing and marketing of pharmaceutical products, had a PBT of Rs 3.1 crore in the year ago quarter.

Meanwhile, operational revenue during the quarter grew 8.8 per cent at Rs 98.49 crore, as against Rs 90.5 crore in the corresponding quarter of the previous year. EBITDA (earnings before interest, tax, depreciation and amortisation)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 31 2019 | 9:39 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com